July 07, 2011
Fearful of drawing attention to suspected links between Listerine and oral cancer, Johnson & Johnson ordered a subsidiary to break a contract to market an oral cancer test in the U.S., a $210 million lawsuit filed Wednesday in New Jersey claims.